Regnante Keith
- SEC CIK
- 0001682068
In the past year, 1 open-market sale filing worth $77.5K and no purchases.
Current role at each company
- KROS Keros Therapeutics, Inc.CHIEF FINANCIAL OFFICERas of Feb 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $77.5K
- 1 filing
- Net
- −$77.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Regnante Keith as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2026 (view filing) | Feb 18 | 2 days | Regnante KeithCHIEF FINANCIAL OFFICER | SSale | −4.74K | $16.35 | −$77.5K | −10.8%39.3K after | |
| Jan 24, 2025 (view filing) | Jan 4, 2024 | 386 days | Regnante KeithCHIEF FINANCIAL OFFICER | SSale | −40.0K | $45.29 | −$1.81M | −100.0%0 after | Amended |
| Jun 12, 2023 (view filing) | Jun 8-9 | 4 days | Regnante KeithChief Financial Officer | SSale | −40.0K | $46.61 | −$1.86M | −100.0%0 after | 5 lots10b5-1 |